Cargando…
Drugging the Epigenome: Overcoming Resistance to Targeted and Immunotherapies in Melanoma
This past decade has seen tremendous advances in understanding the molecular pathogenesis of melanoma and the development of novel effective therapies for melanoma. Targeted therapies and immunotherapies that extend survival of patients with advanced disease have been developed; however, the vast ma...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844701/ https://www.ncbi.nlm.nih.gov/pubmed/35199090 http://dx.doi.org/10.1016/j.xjidi.2021.100090 |